By Reuters Staff
(Reuters) – U.S. drugmaker Acceleron Pharma Inc is in advanced talks to be acquired by a large pharmaceutical company for more than $11 billion, Bloomberg News reported on Friday, citing people familiar with the matter.
The acquisition…
Evaluating The 13.39% Potential Upside In Luxury Goods
February 26, 2026
